We provide necessary pharmaceuticals

A Nordic Specialty Pharma company

Abcur AB (Nordic Division of Concordia International) is a Swedish based pharmaceutical company focusing on the development, registration and marketing of specialized pharmaceutical products. Our main therapeutic areas are addiction, pain management, intensive care and anaesthesia amongst others.

On 21st October 2015, Abcur AB (AMCo Nordics) came under the ownership of the Canadian healthcare business Concordia through their acquisition of AMCo. Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs. It is publicly listed on the TSX/Nasdaq stock exchanges and is headquartered in Oakville, Toronto, Canada. The acquisition creates a leading, international pharmaceutical company, with products available in over 100 countries and operations in many of the major pharmaceutical markets in the world.

READ MORE ABOUT ABCUR

COMMUNITY INVOLVEMENT

Abcur cares, read about our engagement in ethics, environment and how we support charity organisations.

RESEARCH AND DEVELOPMENT

Abcur is involved in development of substances and widening of indications. Read more about our philosophy.

CAREER AT ABCUR

Working at Abcur means that you want to take part in our organisation. Your work and your opinion are valued.

OBSERVERA